Delivery Order SPE2DB24D2205-SPE2DB25FEEXY
- Not listed
- The Defense Logistics Agency awarded a $2,343.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on August 11, 2025, with completion targeted for September 2, 2025. This is a non-set-aside, competitively awarded contract under which AmerisourceBergen will deliver the specified pharmaceutical product to support federal medical supply needs. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $7,030.77 and is scheduled for completion by September 12, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction within...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL auto-injector pens on August 13, 2025, with completion expected by September 4, 2025. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and active through December 2026. The award involved no set-aside designation and...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This competitively awarded, firm fixed-price contract with an ultimate completion date of September 3, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for Tezspire 210 mg/1.91 mL pen auto-injectors valued at $4,687.18 on July 25, 2025. This firm fixed-price contract, with completion scheduled for August 15, 2025, represents a non-set-aside, competitively awarded delivery order issued against AmerisourceBergen's existing indefinite delivery contract vehicle. The pharmaceutical product will be delivered to the contractor's corporate...
- The Defense Logistics Agency awarded a $18,748.72 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with performance completion by September 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger federal contracting vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This firm fixed price contract, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through competitive procurement with no set-aside designation, and performance will occur at the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,343.59 firm fixed price delivery order on August 25, 2025, for Tezspire 210 mg/1.91 mL pen medication with a completion date of September 16, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger federal contract portfolio with DLA. The delivery order is to be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors on July 31, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at approximately $56.2K to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEXYDelivery Order
The Defense Logistics Agency awarded a $9,374.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on July 16, 2025, with completion by August 6, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical supplier within the Defense Health Agency supply chain. The award of Tezspire, a specialty biologic medication for respiratory conditions, reflects DLA's procurement of specialized pharmaceutical products to support military and veteran healthcare systems. AmerisourceBergen's competitive position and extensive federal contracting history demonstrate its capability to fulfill federal medical procurement requirements across diverse therapeutic domains, from routine medications to specialized biologics, supporting military healthcare programs globally through its comprehensive prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 7/16/25 |